Neoadjuvant Trastuzumab, Pertuzumab Plus Metronomic Vinorelbine for Elderly HER2-Positive Breast Cancer

NCT07589972 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer

Interventions

COMBINATION_PRODUCT: neoadjuvant therapy

Sponsor

Tianjin Medical University Cancer Institute and Hospital